Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference

(NASDAQ:OCGN), MALVERN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-founder of Ocugen, will present at the 44th Annual J.P. Morgan Healthcare Conference taking place January 12-15, 2026, at […]

Pomerantz LLP Informs Shareholders of Class Action Against Bitdeer Technologies Group – BTDR

NEW YORK CITY, NY / ACCESS Newswire / January 9, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Bitdeer Technologies Group ("Bitdeer" or the "Company") (NASDAQ:BTDR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Cybeats and Scryb Announce Closing of Shares for Debt Transaction

Toronto, Ontario–(Newsfile Corp. – January 9, 2026) – Cybeats Technologies Corp. (CSE: CYBT) (“Cybeats“) and Scryb Inc. (CSE: SCYB) (“Scryb“) (collectively, the “Companies“) are pleased to announce the closing of the debt settlement transaction previously announced on December 31, 2025 (the “Debt Settlement“). Under the Debt Settlement, Cybeats has settled $1,200,000 owing under a secured debenture held by

CoinUp Announces Release Of Its 2025 Report Card: From Growth to Compliance, the Rise of Second-Tier Exchanges

SINGAPORE, Jan. 09, 2026 (GLOBE NEWSWIRE) — CoinUp announced the release of its 2025 Report Card, detailing a year of accelerated user growth, strengthened regulatory compliance, disciplined product execution, and expanding global presence. As the digital asset industry moves steadily toward institutionalization and clearer regulatory standards, the report highlights how CoinUp and other second-tier exchanges

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA(R)/VAZKEPA(R) (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization

(NASDAQ:AMRN), DUBLIN and BRIDGEWATER, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today commented on recent innovations in therapies for patients with elevated triglycerides (TG) and shared its perspective on how these developments stand to shape patient access and treatment strategies. Specifically,

Aurora Mobile Partners with Xiaoe to Enhance Interaction Efficiency and Support Sustainable Growth in Private Domain Ecosystems

(NASDAQ:JG), SHENZHEN, China, Jan. 09, 2026 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that it has entered into a strategic partnership with Xiaoe Inc. (“Xiaoe”) to integrate its intelligent push notification solution, JPush, into Xiaoe's

Predis.ai Announces Launch of New State-of-the-Art (SOTA) AI Models for Ad Videos

Predis.ai Logo LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) — Predis.ai today announced the launch of new state-of-the-art (SOTA) AI video generation models designed to help businesses more efficiently create and scale high-quality ad creatives or videos for digital advertising platforms such as TikTok and Instagram. The new models aim to address the growing demand

iBio Announces $26 Million Private Placement

(NASDAQ:IBIO), SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) — iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that it has entered into a securities purchase agreement with existing healthcare-focused, high-quality institutional investors for a private placement (“PIPE”) financing that is expected to result in gross proceeds of approximately $26 million to

MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026

(NASDAQ:MPLT), SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) — MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing Phase 2 ZEPHYR and IRIS clinical studies, which are progressing ahead of schedule. The company's Phase 2 ZEPHYR trial evaluating ML-007C-MA for the treatment

VR Upsizes Brokered Private Placement Led by Centurion One Capital to $1,500,000

(TSX-V:VRR),(Boerse Frankfurt – Freiverkehr:5VR.F),(Boerse Frankfurt – Freiverkehr:5VR), NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 09, 2026 (GLOBE NEWSWIRE) — VR Resources Limited (“VR” or the “Company“, TSXV: VRR) announces that due to significant investor demand, it has increased the size of its

Scroll to Top